Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's choice to lead Medicare and Medicaid services. But this could mean a potential ...

Fact checked by Stella Osoba Weight loss drugs are considered an effective way to slim down. While there are health risks, ...

The U.S. Food and Drug Administration (FDA) has officially approved Ozempic to help reduce the risk of ... heart-related problems in these high-risk patients. "Over the last 20 years, it's been ...

29, 2025 -- The FDA has approved Novo Nordisk's diabetes drug Ozempic to help reduce the risk of worsening ... affecting about 40% of patients with diabetes. High blood sugar damages kidney ...

FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes By ... has officially approved Ozempic to help reduce the risk of serious kidney complications in people with type 2 ...

A major analysis of more than 1.2 million medical records has found popular diabetes and weight loss drugs, including Ozempic and Wegovy, may also reduce the risk of other health issues.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications ... depending on the patient's response. In clinical trials, Victoza helped lower ...

One big area of concern for users of GLP-1 medications such as Ozempic and Wegovy is preventing ... muscle growth and maintenance, which could help develop better ways to prevent muscle loss ...